Impact of Agalsidase Alfa Therapy on Cardiac funcTION in Patients With Fabry's Cardiomyopathy
NCT03230591
·
clinicaltrials.gov ↗
UNKNOWN
Status
25
Enrollment
OTHER
Sponsor class
Conditions
Fabry Disease
Interventions
OTHER:
Echocardiography
Sponsor
Yonsei University